"While this supplier issue is not expected to have a material financial impact on BD, we are fully focused on returning the supply of blood culture vials to normal levels," Nikos Pavlidis, president of BD Diagnostic Solutions, said in a statement.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/F39ieug
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment